Organization

Matsuyama Red Cross Hospital

2 abstracts

Abstract
Combination of eribulin with trastuzumab and pertuzumab for HER2 positive advanced or recurrent breast cancer: JBCRG­M03.
Org: Kanagawa Cancer Center, Matsuyama Red Cross Hospital, Nagoya University Graduate School of Medicine, Asahikawa Medical University Hospital, Yokohama City University Medical Center, Yokohama, Japan,
Abstract
ASSOCIATION OF RHEUMATOID FACTOR AND ANTI-CITRULLINATED PROTEIN ANTIBODY STATUS WITH ORTHOPEDIC SURGERIES FOR RHEUMATOID ARTHRITIS PATIENTS
Org: The Centre For Rheumatic Diseases, Matsuyama Red Cross Hospital, Matsuyama, Ehime, Japan, Matsuyama Red Cross Hospital, Ehime University Hospital, Toon, Ehime, Japan, Japan Association for Development of Community Medicine,